PUNE, India, June 28, 2017 /PRNewswire/ --
Radiotherapy market is expected to reach $9.47 billion by 2022 from $6.81 billion in 2017, at a CAGR of 6.8%. Prostate cancer holds the largest share by application while Cancer research institutes will grow at the highest CAGR with APAC region to witness the
Browse 116 tables and 36 figures, 25 Company profiles spread across 222 pages available at:
"Radiotherapy market projected to grow at a CAGR of 6.8%."
The global radiotherapy market is expected to reach USD 9.47 billion by 2022 from USD 6.81 billion in 2017, at a CAGR of 6.8%. The rapidly increasing geriatric population, growing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and rising demand for radiotherapy devices and procedures globally are some of the key factors driving the growth of this market. However, the underdeveloped public health infrastructure in developing nations and the shortage of trained and skilled radiation oncologists are the major factors that are expected to restrain the growth of this market.
Ask For a Sample Copy of Report at: http://www.reportsnreports.com/contacts/requestsample.aspx?name=172707 .
"Prostate cancer holds the largest share of the market by application."
On the basis of application, the radiotherapy market covers external beam radiotherapy and internal beam radiotherapy applications for various cancers. In 2016, the prostate segment held the largest share in both the segments. The growing incidence of prostate cancer and high success rates achieved with external beam radiation are the major factors driving the growth of this market segment.
"Cancer research institutes are expected to grow at the highest CAGR during 2017 to 2022."
On the basis of end user, the cancer research institutes segment is expected to grow at the highest CAGR during the forecast period. The growing awareness about the research applications of radiotherapy devices, development of cost-effective and technologically advanced diagnostic and therapeutic radiotherapy systems, and increasing industry-academia collaborations in the field of research are the key factors driving the demand for radiotherapy techniques among cancer research institutes.
"APAC is projected to witness the highest growth during the forecast period."
North America accounted for the largest share of the market in 2016, followed by Europe and Asia-Pacific. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. The high growth in this segment can be attributed to the growing number of new cancer cases, improvements in healthcare facilities, growing medical tourism, and focus of global players on the emerging nations in Asia-Pacific such as China and India.
Breakdown of supply-side primary interviews: by company type, designation, and region: By Company Type - Tier 1 -20%, Tier 2 -38% and Tier 3 -42%, By Designation - C-level - 15%, Director level - 24%, Others - 61%, By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%
Order a copy of Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022 Research Report at:
Some of the major players in the market are Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan).
Research Coverage of Radiotherapy Industry:
This report studies the radiotherapy market based on product type, type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021 .
Medical Radiation Detection, Monitoring & Safety Market by Detection Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End User - Forecast to 2021 .
Patient Positioning System Market by Product (Tables (Surgical Tables, Radiolucent Imaging Tables), Accessories), Application (Surgery, Cancer Therapy, Disease Diagnosis), and End User (Hospitals, Ambulatory Surgery Center) - Global Forecast to 2022 .
Explore more reports on Medical Devices market at:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact: Ritesh Tiwari 2nd Floor, Metropole Building, Next to Inbox Theatre, Bund Garden Road, Pune - 411001. Maharashtra, India. +1-888-391-5441 firstname.lastname@example.org
Connect with Us: LinkedIn: http://www.linkedin.com/company/reportsnreports RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All